Multiple Sclerosis Therapies Market Size, Trends, Growth, Opportunity And Forecast 2022-2027

According to IMARC Group's latest report, titled "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global multiple sclerosis therapies market size reached US$ 24.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.3 Billion by 2027, exhibiting a growth rate (CAGR) of 4.61% during 2022-2027.

Multiple sclerosis (MS) therapies involve the administration of injectable, infused and oral medicines, antidepressants, muscle relaxants, and physical therapy. They aid in slowing the progression of the disease and managing associated symptoms. Apart from this, they also help in controlling the heart rate and blood pressure and minimizing the frequency of relapses among patients.

Request for a PDF sample of this report: https://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Multiple Sclerosis Therapies Market Trends:

At present, the increasing prevalence of relapsing-remitting and secondary progressive MS across the globe represents one of the primary factors driving the market. Besides this, governing agencies of numerous countries are launching campaigns to generate awareness about the available treatments. This, along with the technological advancements, such as the introduction of innovative immunomodulators, monoclonal bodies, interferons, and immunosuppressants for the effective treatment of MS, is creating a favorable market outlook. Other factors, including considerable improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to stimulate the growth of the market.

Multiple Sclerosis Therapies Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global multiple sclerosis therapies market has also been examined along with the profiles of the key players.

Some of these key players include:
Abbvie Inc.
Bayer Aktiengesellschaft
Biogen Inc.
Bristol-Myers Squibb Company
Hoffmann-La Roche AG (Roche Holding AG)
GlaxoSmithKline Plc
Merck & Co. Inc.
Novartis AG
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.

Key Market Segmentation:

The report has segmented the multiple sclerosis therapies market based on ddrug, drug type, route of administration, distribution channel and region.

Breakup by Drug:
Immunomodulators
Copaxone
Avonex/Plegridy
Gilneya
Tysabri
Betaseron/Extavia
Tecifidera
Rebif
Ampyra
Immunosuppressants
Aubagio
Lemtrada
Ocrelizumab
Zinbryta

Breakup by Drug Type:
Biologic Drugs
Small Molecule Drugs

Breakup by Route of Administration:
Oral
Injectable
Intravenous

Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2571&flag=C

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Apheresis Equipment Market: https://bit.ly/3Tb6ye4

Hospital Infection Therapeutics Market: https://bit.ly/3rJylXC

Portable Medical Ventilators Market: https://bit.ly/3EwfkPQ

Nucleic Acid Labelling Market: https://bit.ly/3yoP1r1

Latin America Generic Drug Market: https://bit.ly/3yvmbW1

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.